MX2011013869A - Agentes antihelminticos y su uso. - Google Patents

Agentes antihelminticos y su uso.

Info

Publication number
MX2011013869A
MX2011013869A MX2011013869A MX2011013869A MX2011013869A MX 2011013869 A MX2011013869 A MX 2011013869A MX 2011013869 A MX2011013869 A MX 2011013869A MX 2011013869 A MX2011013869 A MX 2011013869A MX 2011013869 A MX2011013869 A MX 2011013869A
Authority
MX
Mexico
Prior art keywords
compounds
anthelmintic agents
treatments
directed
processes
Prior art date
Application number
MX2011013869A
Other languages
English (en)
Inventor
Christophe Pierre Alain Chassaing
Thorsten Meyer
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2011013869A publication Critical patent/MX2011013869A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Esta invención se refiere a los compuestos de la fórmula (I) y sales, por tanto, que son generalmente útiles como agentes antihelmínticos o como intermedios en los procedimientos para la fabricación de agentes antihelmínticos; esta invención también se refiere a los procedimientos para la fabricación de los compuestos de esta invención, composiciones farmacéuticas y kits que comprenden los compuestos de esta invención, usos de los compuestos de esta invención para hacer medicamentos y tratamientos que comprende la administración de los compuestos de esta invención a animales en necesidad de los tratamientos.
MX2011013869A 2009-06-18 2010-06-16 Agentes antihelminticos y su uso. MX2011013869A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21826909P 2009-06-18 2009-06-18
EP09163036 2009-06-18
PCT/EP2010/058462 WO2010146083A1 (en) 2009-06-18 2010-06-16 Anthelmintic agents and their use

Publications (1)

Publication Number Publication Date
MX2011013869A true MX2011013869A (es) 2012-02-08

Family

ID=42122924

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011013869A MX2011013869A (es) 2009-06-18 2010-06-16 Agentes antihelminticos y su uso.

Country Status (11)

Country Link
US (1) US8507474B2 (es)
EP (1) EP2443091B1 (es)
CN (1) CN102459186A (es)
AR (1) AR077124A1 (es)
AU (1) AU2010261791B2 (es)
CA (1) CA2765130A1 (es)
MX (1) MX2011013869A (es)
NZ (1) NZ596607A (es)
TW (1) TW201111358A (es)
UY (1) UY32713A (es)
WO (1) WO2010146083A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0904365A2 (pt) * 2009-11-05 2011-11-16 Ouro Fino Participacoes E Empreendimentos S A associações farmacêuticas, composições farmacêuticas, medicamento e método para o tratamento de animais
US9000187B2 (en) 2012-04-20 2015-04-07 Merial, Inc. Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
AU2013348175B2 (en) 2012-11-20 2016-11-17 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic compounds and compositions and method of using thereof
NZ726874A (en) 2014-05-19 2018-03-23 Merial Inc Anthelmintic compounds
JP2017519802A (ja) 2014-07-11 2017-07-20 インターベット インターナショナル ベー． フェー． 犬糸状虫に対する駆虫薬の使用
US20170196854A1 (en) * 2014-07-11 2017-07-13 Intervet Inc. Use of anthelmintic agents against dirofilaria immitis
AU2016209321B2 (en) 2015-01-20 2019-05-09 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic compounds, compositions and method of using thereof
CN111004218B (zh) * 2018-10-08 2023-10-13 沈阳中化农药化工研发有限公司 含哌啶的嘧啶类化合物及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
DE19529604A1 (de) 1995-08-11 1997-02-13 Bayer Ag Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung
TW200406370A (en) * 2002-06-28 2004-05-01 Syngenta Participations Ag 4-(3,3-Dihalo-allyloxy)phenoxy alkyl derivatives
US20120065196A1 (en) 2006-07-21 2012-03-15 Shuji Kitamura Amide compounds

Also Published As

Publication number Publication date
NZ596607A (en) 2013-10-25
UY32713A (es) 2011-01-31
WO2010146083A1 (en) 2010-12-23
US20120094981A1 (en) 2012-04-19
CN102459186A (zh) 2012-05-16
CA2765130A1 (en) 2010-12-23
AU2010261791B2 (en) 2014-12-18
EP2443091A1 (en) 2012-04-25
AR077124A1 (es) 2011-08-03
US8507474B2 (en) 2013-08-13
TW201111358A (en) 2011-04-01
AU2010261791A1 (en) 2011-12-15
EP2443091B1 (en) 2013-04-03

Similar Documents

Publication Publication Date Title
MX2011009847A (es) Agentes antihelminticos y su uso.
CR20200312A (es) Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1
MX348422B (es) Inhibidores de arginasa y sus aplicaciones terapeuticas.
UY32174A (es) Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
MX2012002179A (es) Compuestos heterociclicos de oxima.
NZ708593A (en) Novel pyrazole derivative
MY188960A (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
GEP20146197B (en) New compounds
MX2011013869A (es) Agentes antihelminticos y su uso.
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
UA115558C2 (uk) Алкілпіримідинові похідні для лікування вірусних інфекцій та подальших захворювань
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
MX336381B (es) Boronatos como inhibidores de arginasa.
GEP20146125B (en) Aminopyrimidines as syk inhibitors
MX343706B (es) Derivados heterocíclicos novedosos.
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
EA201100503A1 (ru) Глюкозидные производные и их применения
UA108743C2 (uk) Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази
UA104489C2 (uk) Сполуки для лікування дисліпідемії та споріднених хвороб
EA201390198A1 (ru) Гетероциклическое соединение
MX2012001838A (es) Compuestos de hidrazona heterociclico y sus usos para tratar cancer e inflamacion.
TN2012000534A1 (en) Pyrazole compounds as sigma receptor inhibitors
GB2511685A (en) Muscarinic m1 receptor agonists
EA201391525A1 (ru) Гликозидные производные и их применение для лечения диабета

Legal Events

Date Code Title Description
FA Abandonment or withdrawal